News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Switching Drugs Improves Breast Cancer Survival Rates, Long-Term Trial Data Shows
Changing to an aromatase inhibitor called exemestane after two to three years of tamoxifen treatment can cut women’s risk of dying from breast cancer, according to long-term follow up data from the Intergroup Exemestane Study (IES) published today in the Journal of Clinical Oncology.
Breast Cancer Breakthrough Could Predict Recurrence Risk for Thousands of UK Women
ICR scientists have developed a cost effective test to help identify which of the 37,000 women diagnosed with ER positive breast cancer each year are at risk of the disease returning.
Gene Testing Young Prostate Cancer Patients Could Help Target Treatment
Routinely testing for a faulty BRCA2 gene in under-65s with prostate cancer could help identify men who could benefit from new types of targeted treatment, research led by the ICR shows.
HPV Testing in Screening Programme Saves 3,500 Women From Unncessary Tests
Testing for the human papillomavirus as part of cervical screening reduces the number of women unnecessarily going on for further tests by over a third, according to an analysis led by the ICR.
ICR Scientist to Lead Manchester’s Paterson Institute
Professor Richard Marais has been appointed as the next director of the Paterson Institute for Cancer Research in Manchester.
UK-Discovered Prostate Cancer Drug Launches in Britain
A life-extending new drug to treat patients with advanced prostate cancer, developed by the ICR and The Royal Marsden Hospital, has received its UK license.
International Award for Prostate Cancer Drug Developer
An oncologist from the ICR and The Royal Marsden Hospital who played a leading role in developing important new prostate cancer drugs will this week be honoured with a prestigious European cancer award.
Breakthrough in Male Breast Cancer
The world’s largest study into the genes that cause breast cancer in men reveals similarities with the female disease but also identifies some differences that could potentially lead to tailored treatments.
Launch of New Trial to Treat Recurrent Brain Tumours
The Phase I clinical trial at three centres including the Royal Marsden Hospital and The Institute of Cancer Research is testing a new combination of drugs for the treatment of patients with glioblastoma.
European Approval for UK-Discovered Prostate Cancer Drug
Abiraterone acetate, a drug that extends life for men with advanced prostate cancer and was developed at the ICR and The Royal Marsden Hospital, has today been approved for use throughout Europe.
Vital Funding Continues for Cancer Research
The Royal Marsden NHS Trust, and academic partner, The Institute of Cancer Research (ICR), have been successful in their bid to retain their status as the UK’s only Specialist Biomedical Research Centre (BRC) for Cancer.
Cancers Generate Muscle-Like Contractions to Spread Around the Body
Professor Chris Marshall and colleagues have discovered that a protein called JAK triggers contractions in tumours that allow cancer cells to squeeze though tiny spaces and spread, raising the possibility of new drugs that could stop metastasis.
